In Korea, precision
chemicals out of life science areas have focused on the
limited areas such as Cephem Antibiotics that the advanced
countries didn’t take as a important agent. And also
in the biotechnology area that stands in the
spotlights world wide lately, Korean related
markets have followed thoughtlessly at the
advanced countries’ hill.
In this way, we of
medicine related markets are not strong enough to
make competition with the developed countries
while Korean life science areas will stay behind
the developed countries all the time.
For us to keep up with
them we should develop the state of the art
technology on its own and competitive products by
forecasting the future market
conditions.
Therefore
each Korean company should specialize in its own
area without imitating others' success
Original technology
development and specialized products and furthermore their
affiliation we have to achieve are the only way for the
influence of Korean markets to be extended toward the
world.
I would say
that the innovative medicine and Transgenic
animals development is the potential area where
we can make competition equally against the
advanced enterprises; that is where C-TRI have
aimed at.
I believe
that the success of C-TRI depends not on
marketing but on products. Good products are
resulted from the high technology. So we are
committed to developing creative and original products by
investing aggressively its research and development center;
we of a small but aspiring enterprise will grow and survive
among the competitive global markets as well as domestic
markets based on the cutting edge technology.
